Charles Arntzen

Regents Professor
Biodesign Center for Immunotherapy, Vaccines, and Virotherapy

Location: TEMPE

Contact Information
(480) 225-9412


PhD, 1970, Purdue University, Lafayette, Indiana



Dr. Arntzen served until 1998 on the Board of Directors of DeKalb Genetics, Inc. and on the Board of Directors of Third Wave Agbio, Inc. and on the Scientific Advisory Board for Sumitomo Chemical Company in Osaka, Japan until 2001. He now serves on the Board of Directors of Advanced BioNutrition, Inc., and is on the Advisory Board of the Burrill and Companys Agbio Capital Fund and The Nutraceuticals Fund. He also serves as a Distinguished Advisor on the Council for Biotechnology. From 2001-2008 he served as a member of President George W. Bush's Council of Advisors on Science & Technology in the Office of Science and Technology Policy, and in 2004 he was appointed by the President to serve on the National Nanotechnology Oversight Board from 2004-2008.

Dr. Arntzen's primary research interests are in plant molecular biology and protein engineering, as well as the utilization of plant biotechnology for enhancement of food quality and value, for expression of pharmacologically active products in transgenic plants, and for overcoming health and agricultural constraints in the developing world. He has been recognized as a pioneer in the development of plant-based vaccines for human disease prevention (with special emphasis on needs of poor countries) and for disease prevention in animal agriculture. Recently this research has been extended to creation of effective vaccines and therapeutics to reduce the threats of biowarfare agents.

Dr. Arntzen received his bachelor's and masters degrees from the University of Minnesota and his Ph.D. from Purdue University. He is married to Kathy (Lang) Arntzen, and the father of one son, Christopher Arntzen, a partner in the Corporate Division of the Baker and Botts law firm in Houston, Texas.